Newron Pharmaceuticals SpA (NWRN) — Capital Reinvestment Ratio
Newron Pharmaceuticals SpA (NWRN) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (CHF33.35 Million) in capital expenditures (CHF31.00K). Check Newron Pharmaceuticals SpA tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Newron Pharmaceuticals SpA Capital Reinvestment Ratio (2012–2025)
This chart tracks Newron Pharmaceuticals SpA's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Newron Pharmaceuticals SpA (NWRN) cash conversion ratio.
Annual Capital Reinvestment Ratio for Newron Pharmaceuticals SpA (2012–2025)
Year-by-year Capital Reinvestment Ratio for Newron Pharmaceuticals SpA from 2012 to 2025. See Newron Pharmaceuticals SpA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | CHF32.56 Million | CHF47.30K | ▼ -23.1% |
| 2012 | 0.00x | CHF5.83 Million | CHF11.00K | — |